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Abstract
The identification of high-risk patients with hypertrophic cardiomyopathy (HC) for primary
prevention of sudden cardiac death (SCD) remains a challenging issue, since major risk
factors sometimes lack specificity. We report the case of a patient with HC and association of
apical aneurysm and myocardial bridging who had been initially not implanted because she
had only one major risk factor. She subsequently experienced a sustained ventricular tachycar-
dia that finally motivated the implantation. We conclude that it is never an easy decision to
implant a preventive implantable cardioverter-defibrillator (ICD). Nevertheless, additional
criteria for a better selection of patients who would benefit from an ICD implant are certainly
useful. (Cardiol J 2012; 19, 6: 643–645)
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Introduction
Sudden cardiac death (SCD) is the most deva-
stating and unpredictable outcome in patients suf-
fering from hypertrophic cardiomyopathy (HC).
Whereas in secondary prevention there is a consen-
sus for an implantable cardioverter-defibrillator
(ICD) [1], identification of high-risk patients for
primary prevention of SCD remains a challenging
issue. In clinical practice, patients may have only
one of the recognized risk factors of SCD, and it is
often difficult to largely implant an ICD in all these
patients. Recent reports have focused on new risk
markers, such as the presence of a myocardial
bridging [2], a myocardial fibrosis [3] or an apical
aneurysm [4]. We report here the case of a patient
with HC and association of an apical aneurysm and
myocardial bridging who had been initially not im-
planted, and who subsequently experienced a sus-
tained ventricular tachycardia (VT) with a very high
level of troponin that finally motivated the implan-
tation.
Case report
The patient is a 48 year-old woman, who has
been followed since 2001 for a HC. She had no per-
sonal history of syncope, no familial history of SCD
or even HC. An initial echocardiography assessed
a septo-apical dominant HC (thickness 17 mm),
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posterior wall thickness of 16 mm, and a left ven-
tricular ejection fraction of 62%. There was neither
mitral valve systolic anterior motion, nor left ven-
tricular outflow tract obstruction. At that time, she
had non-sustained VT on a 24-hour ambulatory ECG
recording, before any beta-blocker treatment was
initiated.
Two years later, she consulted due to a tran-
sient diplopia: cerebral magnetic resonance imag-
ing (MRI) was normal, but the echocardiography
showed an increased hypertrophy with a 19 mm
septum thickness and the appearance of an apical
aneurysm. Cardiac MRI confirmed such an apical
aneurysm, with a small thrombus and an apical de-
layed enhancement that could correspond to fibro-
sis or a healed myocardial infarction. As the patient
was also an active smoker, a coronarography was
performed and showed a mid left anterior descend-
ing (LAD) coronary artery bridging, but no coronary
stenosis. We decided to begin anticoagulant medi-
cation.
Since this episode, the patient remained
asymptomatic with normal treadmill test, repetitive
Holter still showing mild ventricular excitability,
and stable hypertrophy and fibrosis with no outflow
obstruction on either contrast-enhanced echocar-
diography or the last cardiac MRI performed in July
2009. However, at that time she was referred in our
institution to discuss a primary prevention of an
ICD. Despite the association of one recognized risk
factor of SCD (non-sustained VT) with this apical
aneurysm, we postponed ICD implantation in this
asymptomatic patient because of the unusual aspect
of this aneurysm that differed from the description
by Maron et al. [4].
In December 2010, the patient presented diz-
ziness with palpitations. On physical examination,
pulse was regular at 180 bpm and blood pressure
stable. Twelve-lead ECG revealed a monomorphic
VT coming from the apical aspect of the left ventri-
cle (Fig. 1). After restoration of sinus rhythm, we
unexpectedly found a highly increased troponin le-
vel of 90 mg/L. Coronarography still showed the
known mid-LAD coronary artery bridging, without
any coronary stenosis (Fig. 2). CMR showed a larg-
er apical aneurysm with a transmural fibrosis and
severe mid-ventricular hypertrophy with a septal
thickness now at 26 mm (Fig. 2). We postulated that
VT might be related to the natural history of this
HC with an apical aneurysm, or because of this high
level of troponin and this increasing apical aneu-
rysm, secondary to an ischemic event due to this
LAD bridging. After careful discussion, because of
this large transmural scar with no evidence of via-
bility at the MRI, neither LAD angioplasty nor sur-
gical bypass was done, while the implantation of an
ICD as secondary prevention was scheduled.
Discussion
The decision for preventive implantation of
ICD in patients with HC is often difficult because
patients frequently display only one recognized risk
factor. Although a large cohort study has shown that
one risk factor could justify ICD implantation [5], it
is also important to keep in mind that the rate of
complications related to the device is unacceptably
high. And patients with HC may also suddenly die
even in the absence of any risk marker [1]. As
a result, it is of great importance to seek additional
Figure 1. ECG when patient presented dizziness and palpitations with ventricular tachycardia.
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Figure 2. A. Coronarography showing myocardial bridging of the left anterior descending coronary artery in systole (left)
and diastole (right); B. Cardiac resonance imaging showing predominant septal hypertrophy and apical aneurysm.
criteria for a better selection of patients who would
benefit from an ICD implantation. Recently, the
presence of a left ventricular apical aneurysm in HC,
a large zone of fibrosis or a myocardial bridging have
been correlated to a higher SCD rate [2–4]. In this
case report, the patient had both an apical aneurysm
and a myocardial bridging.
Because of the late appearance of this aneu-
rysm with initially a thrombus concomitantly to the
occurrence of a stroke, and the recent VT episode
associated with this high level of troponin, we
thought that this apical aneurysm could be related
to this LAD bridging and so is a consequence of
repeated ischemic events.
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